RE: Buy back program - no action31 Jan 2024 14:20
I do have access:
Basically, nothing new. Also, they are not independent research. Canaccord is intertwined with Agronomics.
A little excerpt from the summary of the report:
ANIC's portfolio companies, BlueNalu, All G Foods, and Onego Bio, should all demonstrate regulatory success in 2H24, validating and de-risking the portfolio as a whole.
Valuation: We remain BUYers with an unchanged target price of 20p. We reiterate BUY at 20p. We continue to base our value on our expected NAV as of end March 2024.